REVOLUTION MEDICINES INC's ticker is RVMD and the CUSIP is 76155X100. A total of 135 filers reported holding REVOLUTION MEDICINES INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 1.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $572,727 | +627.0% | 20,691 | +602.6% | 0.02% | +500.0% |
| Q2 2023 | $78,779 | +106358.1% | 2,945 | -13.8% | 0.00% | +50.0% |
| Q1 2023 | $74 | +60.9% | 3,418 | +76.5% | 0.00% | 0.0% |
| Q4 2022 | $46 | -100.0% | 1,937 | -67.5% | 0.00% | 0.0% |
| Q3 2022 | $117,000 | -4.9% | 5,951 | -5.8% | 0.00% | -33.3% |
| Q2 2022 | $123,000 | -35.3% | 6,319 | -15.1% | 0.00% | +50.0% |
| Q1 2022 | $190,000 | +1.1% | 7,439 | -0.6% | 0.00% | -33.3% |
| Q4 2021 | $188,000 | +12.6% | 7,483 | +23.4% | 0.00% | -25.0% |
| Q3 2021 | $167,000 | +24.6% | 6,066 | +43.8% | 0.00% | +33.3% |
| Q2 2021 | $134,000 | +42.6% | 4,219 | +106.5% | 0.00% | +50.0% |
| Q1 2021 | $94,000 | -38.6% | 2,043 | -47.1% | 0.00% | -60.0% |
| Q4 2020 | $153,000 | -57.1% | 3,863 | -62.3% | 0.01% | +25.0% |
| Q3 2020 | $357,000 | +301.1% | 10,247 | +262.5% | 0.00% | 0.0% |
| Q2 2020 | $89,000 | – | 2,827 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nextech Invest Ltd. | 4,839,529 | $133,958,163 | 40.59% |
| Column Group LLC | 1,230,641 | $34,064,143 | 22.62% |
| Boxer Capital, LLC | 4,684,264 | $129,660,428 | 6.90% |
| Finepoint Capital LP | 427,000 | $11,819,360 | 5.89% |
| Casdin Capital, LLC | 1,810,000 | $50,100,800 | 5.54% |
| EcoR1 Capital, LLC | 5,577,863 | $154,395,248 | 5.21% |
| DAFNA Capital Management LLC | 473,394 | $13,103,546 | 4.08% |
| Artal Group S.A. | 2,529,737 | $70,023 | 3.00% |
| BVF INC/IL | 3,981,212 | $110,199,948 | 2.97% |
| Bellevue Group AG | 4,721,500 | $130,691,120 | 2.11% |